Table 1.
Tissue distribution of KLFs.
| Human KLFs | Top 3 expressing tissues (RPKM) | Heart (RPKM) |
|---|---|---|
| KLF1 | Bone marrow, placenta, spleen | N/A |
| KLF2 | Fat, ovary, bone marrow | 4.09 |
| KLF3 | Colon, gall bladder, esophagus | 4.69 |
| KLF4 | Colon, esophagus, skin | 9.10 |
| KLF5 | Skin, esophagus, colon | 0.79 |
| KLF6 | Bone marrow, gall bladder, esophagus | 13.44 |
| KLF7 | Bone marrow, endometrium, fat | 1.51 |
| KLF8 | Skin, fat, esophagus | 0.54 |
| KLF9 | Fat, gall bladder, liver | 16.83 |
| KLF10 | Bone marrow, gall bladder, lung | 10.54 |
| KLF11 | Testis, lung, fat | 6.47 |
| KLF12 | Lymph node, spleen, brain | 2.17 |
| KLF13 | Bone marrow, lung, thyroid | 11.78 |
| KLF14 | Testis, adrenal gland, fat | N/A |
| KLF15 | Fat, ovary, kidney | 2.13 |
| KLF16 | Brain, colon, spleen | 0.73 |
| KLF17 | Testis, endometrium, esophagus | 0.003 |
Summary of the KLF abundance as calculated here from the HPA RNA-seq analysis of normal tissue samples from 95 human individuals representing 27 different tissues (Fagerberg et al., 2014). The reads per kilobase per million mapped reads (RPKM) for KLFs in the top 3 KLF-expressing tissues and heart are listed in the table. N/A, not available.